1. Home
  2. WLDS vs NXL Comparison

WLDS vs NXL Comparison

Compare WLDS & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

N/A

Current Price

$1.25

Market Cap

7.7M

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

N/A

Current Price

$1.51

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLDS
NXL
Founded
2014
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
WLDS
NXL
Price
$1.25
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 29.6K
26.6K
Earning Date
08-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.76
EPS
★ N/A
N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.04
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$0.63
$0.22
52 Week High
$6.50
$67.20

Technical Indicators

Market Signals
Indicator
WLDS
NXL
Relative Strength Index (RSI) 39.32 32.34
Support Level $1.22 $1.31
Resistance Level $1.48 $5.36
Average True Range (ATR) 0.14 0.15
MACD -0.01 0.15
Stochastic Oscillator 3.00 47.15

Price Performance

Historical Comparison
WLDS
NXL

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: